Changes in Control Form 8 K

Item 5.01 Changes in Control of Registrant.

On November 1, 2024, Ryan D. Faber, Jesse J. Leimgruber, John C. Backus III and Alain P. Meier (the "Founder Sellers") and Virtual Assets Lab AG, a Swiss company limited by shares (the "Purchaser") entered into and consummated a share purchase agreement (the "Share Purchase Agreement"), pursuant to which the Purchaser acquired all of the Company's outstanding voting and nonvoting limited liability company units (such acquisition, the "Transaction").

The consideration in the Transaction, which is being delivered, subject to certain escrows that among other things support the Company's compliance with its reporting obligations, by wire transfer of immediately available funds consists of (i) (a) $20.4 million, which is the total amount of cash and cash equivalents held by the Company as of 8:00 a.m. EST on November 1, 2024, plus (b) $2.8 million in connection with Mr. Leimgruber's repayment (using funds he otherwise would have received as a Founder Seller) of the previously disclosed promissory note agreement dated July 18, 2022, pursuant to which the Company loaned to Mr. Leimgruber an aggregate principal amount of $2.6 million at an interest rate of 3.17% per annum, compounded monthly; and (ii) rights to certain additional consideration, summarized below, in accordance with a contingent consideration side letter entered into on November 1, 2024 by and among the Founder Sellers and the Purchaser (the "Contingent Consideration Side Letter").

The Share Purchase Agreement contains customary representations, warranties, indemnities, escrows and covenants of the Purchaser and the Founder Sellers. The parties have agreed to indemnify each other for certain breaches of representations, warranties and covenants.

In accordance with the Contingent Consideration Side Letter, subject to certain adjustments, the Purchaser agreed to pay to the Sellers a five percent contingent payment in cash on all Revenue earned from the sale, licensing or use of the Company's Technology (as such terms are defined in the Contingent Consideration Side Letter) by the Purchaser or its affiliates. The terms of the Contingent Consideration Side Letter commenced on October 31, 2024, and expire on the earlier of (i) the date that is five years from October 31, 2024 or (ii) the date that is two years from October 31, 2024 if the Sellers' Representative (as such term is defined therein) determines that the Purchaser has not taken Reasonable Steps (as such term is defined therein) to utilize the Technology as part of its commercial offerings. In addition, if the Purchaser fails to take Reasonable Steps or engages in uncured Events of Default (as such terms are defined in the Contingent Consideration Side Letter), the Company's Technology automatically reverts to the Sellers. Contingent payments shall be paid annually, commencing on the one year anniversary of October 31, 2024 and on each anniversary thereafter, through the term of the Contingent Consideration Side Letter.

The descriptions of the Share Purchase Agreement and the Contingent Consideration Side Letter set forth above do not purport to be complete and are qualified in their entirety by reference to the full text of the Share Purchase Agreement and the Contingent Consideration Side Letter, copies of which are filed as Exhibit 10.1 and Exhibit 10.2, respectively, to this Current Report on Form 8-K. The Share Purchase Agreement, Contingent Consideration Side Letter and the above description have been included to provide investors with information regarding the terms of those agreements. Neither the Share Purchase Agreement nor the Contingent Consideration Side Letter is intended to provide any other factual information about the Company or any other parties to those agreements or their respective affiliates or equityholders. The representations, warranties and covenants contained in these agreements were made only for the purposes of the those agreements and as of the specific dates, were solely for the benefit of the parties thereto, may have been used for purposes of allocating risk between each party rather than establishing matters of fact, may be subject to a contractual standard of materiality different from that generally applicable to investors and may be subject to qualifications or limitations agreed upon by the parties in connection with the negotiated terms, including being qualified by schedules and other disclosures made by each party. Accordingly, investors should not rely on the representations, warranties and covenants in the Share Purchase Agreement or the Contingent Consideration Side Letter as statements of factual information.

This Current Report on Form 8-K does not constitute an offer to sell or the solicitation of an offer to buy any securities.